Consider Cell Therapy GMP Manufacturing Early in Development

Small biotechs in early development of cell therapies are often surprised by the strictness of commercial manufacturing standards. That’s the view of Luděk Sojka, PhD, CEO of contract developer and manufacturer SCTbio. Sojka, who spoke at the Terrapinn conference on...

The price of hope: CAR-T therapy in pediatric leukemia

We stand at the crossroads of medical innovation, where cutting-edge scientific discoveries intersect with the resilience of the human body, providing hope to families grappling with a diagnosis of pediatric leukemia. In an editorial paper, published in Oncoscience...